BioDuro offers fully integrated drug discovery and development services tailored to accelerate biopharma innovation from target identification to IND submission, until commercial manufacturing. Our global team of 2000+ scientists supports programs across key therapeutic areas with capabilities spanning Discovery Chemistry, Biology, DMPK, in vitro/in vivo pharmacology, Drug substance and Drug Product. With a focus on complex modalities such as ADCs, peptides, and GLP-1 receptor agonists, BioDuro combines deep scientific expertise with flexible engagement models to help clients rapidly progress from early discovery through development to commercial. Our end-to-end approach ensures seamless coordination across disciplines, enabling faster timelines and greater success in translating science into new therapies.